                         SEQUENCE LISTING

<110>  CONSEJO SUPERIOR DE INVESTIGACIONES CIENTFICAS
 
<120>  IL13Ralpha2 PEPTIDE AND ITS USES

<130>  PCT1641.1368

<150>  EP17382737
<151>  2017-11-03

<160>  13    

<170>  PatentIn version 3.5

<210>  1
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide derived from IL13Ralpha2

<400>  1

Trp Lys Thr Ile Ile Thr Lys Asn 
1               5               


<210>  2
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Inhibitory peptide of IL13/IL13Ralpha2 signalling


<220>
<221>  VARIANT
<222>  (1)..(1)
<223>  /replace="Phe" /replace="Tyr"

<220>
<221>  VARIANT
<222>  (2)..(2)
<223>  /replace="Arg"

<220>
<221>  VARIANT
<222>  (3)..(3)
<223>  /replace="Ser"

<220>
<221>  VARIANT
<222>  (4)..(4)
<223>  /replace="Ala" /replace="Leu" /replace="Met" /replace="Val"

<220>
<221>  VARIANT
<222>  (5)..(5)
<223>  /replace="Leu" /replace="Met" /replace="Val"

<220>
<221>  VARIANT
<222>  (6)..(6)
<223>  /replace="Ser"

<220>
<221>  VARIANT
<222>  (7)..(7)
<223>  /replace="Ala" /replace="Arg"

<220>
<221>  VARIANT
<222>  (8)..(8)
<223>  /replace="Gln"

<400>  2

Trp Lys Thr Ile Ile Thr Lys Asn 
1               5               


<210>  3
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Inhibitory peptide of IL13/IL13Ralpha2 signalling

<400>  3

Gly Ser Glu Thr Trp Lys Thr Ile Ile Thr Lys Asn 
1               5                   10          


<210>  4
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Inhibitory peptide of IL13/IL13Ralpha2 signalling

<400>  4

Trp Lys Thr Ala Ile Thr Ala Asn 
1               5               


<210>  5
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Inhibitory peptide of IL13/IL13Ralpha2 signalling

<400>  5

Trp Arg Thr Ile Ile Thr Lys Asn 
1               5               


<210>  6
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Inhibitory peptide of IL13/IL13Ralpha2 signalling

<400>  6

Trp Lys Thr Ile Ile Thr Arg Asn 
1               5               


<210>  7
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Inhibitory peptide of IL13/IL13Ralpha2 signalling

<400>  7

Trp Lys Thr Val Ile Thr Lys Asn 
1               5               


<210>  8
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Inhibitory peptide of IL13/IL13Ralpha2 signalling

<400>  8

Trp Lys Thr Ile Val Thr Lys Asn 
1               5               


<210>  9
<211>  380
<212>  PRT
<213>  Homo sapiens

<400>  9

Met Ala Phe Val Cys Leu Ala Ile Gly Cys Leu Tyr Thr Phe Leu Ile 
1               5                   10                  15      


Ser Thr Thr Phe Gly Cys Thr Ser Ser Ser Asp Thr Glu Ile Lys Val 
            20                  25                  30          


Asn Pro Pro Gln Asp Phe Glu Ile Val Asp Pro Gly Tyr Leu Gly Tyr 
        35                  40                  45              


Leu Tyr Leu Gln Trp Gln Pro Pro Leu Ser Leu Asp His Phe Lys Glu 
    50                  55                  60                  


Cys Thr Val Glu Tyr Glu Leu Lys Tyr Arg Asn Ile Gly Ser Glu Thr 
65                  70                  75                  80  


Trp Lys Thr Ile Ile Thr Lys Asn Leu His Tyr Lys Asp Gly Phe Asp 
                85                  90                  95      


Leu Asn Lys Gly Ile Glu Ala Lys Ile His Thr Leu Leu Pro Trp Gln 
            100                 105                 110         


Cys Thr Asn Gly Ser Glu Val Gln Ser Ser Trp Ala Glu Thr Thr Tyr 
        115                 120                 125             


Trp Ile Ser Pro Gln Gly Ile Pro Glu Thr Lys Val Gln Asp Met Asp 
    130                 135                 140                 


Cys Val Tyr Tyr Asn Trp Gln Tyr Leu Leu Cys Ser Trp Lys Pro Gly 
145                 150                 155                 160 


Ile Gly Val Leu Leu Asp Thr Asn Tyr Asn Leu Phe Tyr Trp Tyr Glu 
                165                 170                 175     


Gly Leu Asp His Ala Leu Gln Cys Val Asp Tyr Ile Lys Ala Asp Gly 
            180                 185                 190         


Gln Asn Ile Gly Cys Arg Phe Pro Tyr Leu Glu Ala Ser Asp Tyr Lys 
        195                 200                 205             


Asp Phe Tyr Ile Cys Val Asn Gly Ser Ser Glu Asn Lys Pro Ile Arg 
    210                 215                 220                 


Ser Ser Tyr Phe Thr Phe Gln Leu Gln Asn Ile Val Lys Pro Leu Pro 
225                 230                 235                 240 


Pro Val Tyr Leu Thr Phe Thr Arg Glu Ser Ser Cys Glu Ile Lys Leu 
                245                 250                 255     


Lys Trp Ser Ile Pro Leu Gly Pro Ile Pro Ala Arg Cys Phe Asp Tyr 
            260                 265                 270         


Glu Ile Glu Ile Arg Glu Asp Asp Thr Thr Leu Val Thr Ala Thr Val 
        275                 280                 285             


Glu Asn Glu Thr Tyr Thr Leu Lys Thr Thr Asn Glu Thr Arg Gln Leu 
    290                 295                 300                 


Cys Phe Val Val Arg Ser Lys Val Asn Ile Tyr Cys Ser Asp Asp Gly 
305                 310                 315                 320 


Ile Trp Ser Glu Trp Ser Asp Lys Gln Cys Trp Glu Gly Glu Asp Leu 
                325                 330                 335     


Ser Lys Lys Thr Leu Leu Arg Phe Trp Leu Pro Phe Gly Phe Ile Leu 
            340                 345                 350         


Ile Leu Val Ile Phe Val Thr Gly Leu Leu Leu Arg Lys Pro Asn Thr 
        355                 360                 365             


Tyr Pro Lys Met Ile Pro Glu Phe Phe Cys Asp Thr 
    370                 375                 380 


<210>  10
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Inhibitory peptide of IL13/IL13Ralpha2 signalling


<220>
<221>  VARIANT
<222>  (5)..(5)
<223>  Xaa can be selected from: Trp,  Phe or Tyr

<220>
<221>  VARIANT
<222>  (6)..(6)
<223>  Xaa can be selected from: Lys or Arg

<220>
<221>  VARIANT
<222>  (7)..(7)
<223>  Xaa can be selected from: Thr or Ser

<220>
<221>  VARIANT
<222>  (8)..(8)
<223>  Xaa can be selected from: Ile, Ala, Leu, Met or Val

<220>
<221>  VARIANT
<222>  (9)..(9)
<223>  Xaa can be selected from: Ile, Leu, Met or Val

<220>
<221>  VARIANT
<222>  (10)..(10)
<223>  Xaa can be selected from: Tyr or Ser

<220>
<221>  VARIANT
<222>  (11)..(11)
<223>  Xaa can be selected from: Lys, Ala or Arg

<220>
<221>  VARIANT
<222>  (12)..(12)
<223>  Xaa can be selected from: Asn or Gln

<400>  10

Gly Ser Glu Thr Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa 
1               5                   10          


<210>  11
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide J

<400>  11

Gly Ser Glu Thr 
1               


<210>  12
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Reversed sequence of SEQ ID NO: 1

<400>  12

Asn Lys Thr Ile Ile Thr Lys Trp 
1               5               


<210>  13
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Reverse sequence of SEQ ID NO: 3

<400>  13

Asn Lys Thr Ile Ile Thr Lys Trp Thr Glu Ser Gly 
1               5                   10          


